Clinical Study of a Single Ciliopathy: Alström Syndrome
Safety and Tolerability of PBI-4050 and Its Effects on the Biomarkers in Subjects With Alström Syndrome
Setmelanotide Phase 2 Treatment Trial in Patients With Rare Genetic Disorders of Obesity
|4||Active, not recruiting||
Clinical and Molecular Investigations Into Ciliopathies
† Study has passed its completion date and status has not been verified in more than two years.